I wanted to provide an update on the suggested list of incentivized assets for Namada. Initially, I included Injective’s INJ as a potential day-1 incentivized asset. After further consideration, I’ve decided to remove INJ from my proposal to better align with the strategy of rotating assets into the incentivized list over time. This approach allows Namada to keep multiple communities engaged while managing inflation responsibly.
Additionally, there is a technical hurdle related to INJ that would be more ideal to address at a later stage. I believe it would also be beneficial to take the time to develop a stronger relationship with the Injective team and their community before moving forward. While INJ won’t be incentivized day 1, it remains a strong candidate for future incentives. I appreciate your feedback.